A novel anticancer and antifungus phenazine derivative from a marine actinomycete BM-17

Microbiological Research

Volumn 167, Issue 10, 2012, Pages 616-622

  Gao, Xiaochun ^a   Lu, Yuanyuan ^a   Xing, Yingying ^a   Ma, Yihua ^a   Lu, Jiansheng ^a   Bao, Weiwei ^a   Wang, Yiming ^a   Xi, Tao ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Marine actinomycete BM 17; Secondary metabolite; Spectroscopy

Indexed keywords

16S RDNA; ANTI-FUNGAL ACTIVITY; ARCTIC OCEAN; BIOCHEMICAL CHARACTERISTICS; CANCER CELLS; CANDIDA ALBICANS; CELL WALLS; CULTURE BROTHS; GENE SEQUENCE ANALYSIS; MACROPOROUS RESIN; MARINE ACTINOMYCETE; NOCARDIA; PREPARATIVE HPLC; SECONDARY METABOLITES; SEDIMENT SAMPLES; SEPHADEX;

CELL CULTURE; ION EXCHANGE; METABOLITES; SILICA GEL; SPECTROSCOPIC ANALYSIS; SPECTROSCOPY;

BACTERIA;

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; BIOLOGICAL PRODUCT; PHENAZINE DERIVATIVE;

ANTIBIOTICS; ANTIMICROBIAL ACTIVITY; BACTERIUM; BIOCHEMICAL COMPOSITION; CANCER; DATA SET; DEVELOPMENTAL BIOLOGY; GEL; MARINE ENVIRONMENT; ORGANIC COMPOUND; SECONDARY METABOLITE; SOYBEAN; TOXICITY; TWO-DIMENSIONAL MODELING;

ACTINOBACTERIA; ARCTIC; ARTICLE; CANDIDA ALBICANS; CHEMISTRY; CLASSIFICATION; DRUG EFFECT; GENETICS; ISOLATION AND PURIFICATION; MARINE BIOLOGY; METABOLISM; METHODOLOGY; NOCARDIA; SEA;

ACTINOBACTERIA; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ANTINEOPLASTIC AGENTS; ARCTIC REGIONS; BIOLOGICAL AGENTS; CANDIDA ALBICANS; MARINE BIOLOGY; NOCARDIA; OCEANS AND SEAS; PHENAZINES;

ARCTIC OCEAN;

ACTINOBACTERIA; CANDIDA ALBICANS; GLYCINE MAX; NOCARDIA; NOCARDIOPSIS DASSONVILLEI;

EID: 84867900654     PISSN: 09445013     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micres.2012.02.008     Document Type: Article

References (62)

1. Abdelfattah M.S., Kazufumi T., Ishibashi M. Isolation and structure elucidation of izuminosides A-C: a rare phenazine glycosides from Streptomyces sp. IFM 11260. J Antibiot 2011, 64:271-275.
2. Abdelfattah M.S., Kazufumi T., Ishibashi M. New pyranonaphthoquinones and a phenazine alkaloid isolated from Streptomyces sp., IFM 11307 with TRAIL resistance-overcoming activity. J Antibiot 2011, 64:729-734.
3. Abken H.J., Tietze M., Brodersen J., Bäumer S., Beifuss U., Deppenmeier U. Isolation and characterization of methanophenazine and function of phenazines in membrane-bound electron transport of Methanosarcina mazei Gö1. J Bacteriol 1998, 180(8):2027-2032.
4. Amann R.I., Ludwig W., Schleifer K.H. Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbiol Rev 1995, 59:143-169.
5. Bentley S.D., Chater K.F., Cerdeno-Tárraga A.M., Challis G.L., Thomson N.R., James K.D., et al. Complete genome sequence of the model actinomycete Streptomyces Coelicolor A3(2). Nature (Lond) 2002, 417:141-147.
6. Berdy J. Bioactive microbial metabolites. J Antibiot 2005, 58:1-26.
7. Bernan V.S., Greenstein M., Carter G.T. Mining marine microorganisms as a source of new antimicrobials and antifungals. Curr Med Chem: Anti-infect Agents 2004, 3:181-195.
8. Bitzer J., Große T., Wang L., Lang S., Beil W., Zeeck A. New aminophenoxazinones from a marine Halomonas sp.: fermentation, structure elucidation, and biological activity. J Antibiot 2006, 59(2):86-92.
9. Blunt J.W., Copp B.R., Munro M.H., Northcote P.T., Prinsep M.R. Marine natural products. Nat Prod Rep 2006, 23:26-78.
10. Blunt J.W., Copp B.R., Hu W.P., Munro M.H., Northcote P.T., Prinsep M.R. Marine natural products. Nat Prod Rep 2009, 26:170-244.
11. Breitmaier E. Carbon-13 nuclear magnetic resonance chemical shifts of substituted phenazines. J Org Chem 1976, 41(12):2104-2108.
12. Brosius J., Palmer M.L., Kennnedy P.J., Noller H.F. Complete nucleotide sequence of a 16S ribosomal RNA gene from Escherichia coli. Proc Natl Acad Sci U S A 1978, 75:4801-4805.
13. Cai P., Kong F.M., Ruppen M.E., Glasier G., Carter G.T. Hygrocins A and B Naphthoquinone Macrolides from Streptomyces. J Nat Prod 2005, 68:1736-1742.
14. Cross J.V., Deak J.C., Rich E.A., Qian Y.Y., Lewis M., Parrott L.A., et al. Quinone reductase inhibitors block SAPK/JNK and NF Kappa B pathways and potentiate apoptosis. J Biol Chem 1999, 274:31150-31154.
15. D'Amico S., Collins T., Marx J.C., Feller G., Gerday C. Psychrophilic microorganisms: challenges for life. EMBO Rep 2006, 7:385-389.
16. de Andrade-Neto V., Goulart M.O.F., da Silva Filho J.F., da Silva M.J., Pinto M.C.F.R., Pinto A.V., et al. Antimalarial activity of phenazines from lapachol, β-lapachone and its derivatives against Plasmodium falciparum in vitro and Plasmodium berghei in vivo. Bioorg Med Chem Lett 2004, 14:1145-1149.
17. DeLong E.F. Marine microbial diversity: the tip of the iceberg. Trends Biotechnol 1997, 15:203-207.
18. Demain A.L., Sanchez S. Microbial drug discovery: 80 years of progress. J Antibiot 2009, 62:5-16.
19. Ellaiah P., Kalyan D., Rao V.S., Rao B.V. Isolation and characterization of bioactive actinomycetes from marine sediments. Hindustan Antibiot Bull 1996, 38:48-52.
20. Fabian M.A., Biggs W.H., Treiber D.K., Atteridge C.E., Azimioara M.D., Benedetti M.G., et al. A small molecule-kinase interaction map for clinical kinase inhibitors. Nat Biotechnol 2005, 23:329-336.
21. Fenical W., Sethna K.M., Lloyd G.K. Marine microorganisms as a developing resource for drug discovery. Pharm News 2002, 9:489-494.
22. Gerber N.N. Phenazines: phenoxazinones, and dioxopiperazines from Streptomyces thioluteus. J Org Chem 1967, 32(12):4055-4057.
23. Haagen Y., Gück K., Fay K., Kammerer B., Gust B., Heide L. A gene cluster for prenylated naphthoquinone and prenylated phenazine biosynthesis in Streptomyces cinnamonensis DSM 1042. Chembiochem 2006, 7:2016-2027.
24. Hancock R.E.W. The end of an era?. Nat Rev Drug Discov 2007, 6:28.
25. Holding A.J., Collee Routine biochemical tests. Methods Microbiol 1971, 6:1-31.
26. Hosoya Y., Adachi H., Nakamura H., Nishimura Y., Naganawa H., Okami Y., et al. The structure of diphenazithionin: a novel antioxidant from Streptomyces griseus ISP 5236. Tetrahedron Lett 1996, 37(51):9227-9228.
27. Hugenholtz P., Pace N.R. Identifying microbial diversity in the natural environment: a molecular phylogenetic approach. Trends Biotechnol 1996, 14:190-197.
28. Imamura N., Nishijima M., Takadera T., Adachi K., Sakai M., Sano H. A new anticancer antibiotics pelagiomicins: produced by a new marine bacterium Pelagiobacter variabilis. J Antibiot 1997, 50(1):8-12.
29. Jin X., Gossett D.R., Wang S., Yang D., Cao Y., Chen J., et al. Inhibition of AKT aurvival pathway by a small molecule inhibitor in human endometrial cancer cells. Br J Cancer 2004, 91:1808-1812.
30. Kim W.G., Ryoo I.J., Yun B.S., Shin-ya K., Seto H., Yoo I.D. New diphenazines with neuronal cell protecting activity: phenazostatins A and B, produced by Streptomyces sp. J Antibiot 1997, 50(9):715-721.
31. Kumar S., Tamura K., Jakobsen I.B., Nei M. MEGA 2: molecular evolutionary genetics analysis software. Bioinformatics 2001, 17:1244-1245.
32. Kunigami T., Shin-ya K., Furihata K., Furihata K., Hayakawa Y., Seto H. A novel neuronal cell protecting substance: aestivophoenin C, produced by Streptomyces purpeofuscus. J Antibiot 1998, 51(9):880-882.
33. Laursen J.B., Nielsen J. Phenazine natural products: biosynthesis, synthetic analogues, and biological activity. Chem Rev 2004, 104:1663-1685.
34. Liu H., He Y., Jiang H., Peng H., Huang X., Zhang X., et al. Characterization of a phenazine-producing strain Pseudomonas chlororaphis GP72 with broad-spectrum antifungal activity from green pepper rhizosphere. Curr Microbiol 2007, 54:302-306.
35. Liu W.H., Li M.G., Li Y.Q., Zhao J.Y., Ding Z.G., Yang P.W., et al. Cytotoxic metabolites of streptimonospora salina. Chem Nat Compd 2008, 44(4):503-505.
36. Maheshwari R.K., Singh A.K., Gaddipati J., Srimal R.C. Multiple biological activities of curcumin: a short review. Life Sci 2006, 78:2081-2087.
37. Makgatho M.E., Anderson R., O'Sullivan J.F., Egan T.J., Freese J.A., Cornelius N., et al. Tetramethylpiperidine-substituted phenazines as novel anti-plasmodial agents. Drug Dev Res 2000, 50:195-202.
38. Manson M.M., Holloway K.A., Howells L.M., Hudson E.A., Plummer S.M., Squires M.S., et al. Modulation of signal-transduction pathways by chemopreventive agents. Biochem Soc Trans 2000, 28:7-12.
39. Mavrodi D.V., Blankenfeldt W., Thomashow L.S., Mentel M. Phenazine compounds in fluorescent Pseudomonas spp biosynthesis and regulation. Annu Rev Phytopathol 2006, 44:417-445.
40. Mayer A.M., Rodríguez A.D., Berlinck R.G., Hamann M.T. Marine pharmacology in 2003-4 marine compounds with anthelmintic antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action. Comp Biochem Physiol 2007, 145:553-581.
41. Mikami Y. Biological work on medically important Nocardia species. Actinomycetologica 2007, 21:46-51.
42. Neidlein R., Kramer W., Leidholdt R. Usefulness of carbon-13 substituent increments in 1,4-benzo-and 1,4-naphthoquinones. Helv Chim Acta 1983, 66(7):2285-2293.
43. Olano C., Méndez C., Salas J.A. Antitumor compounds from marine actinomycetes. Mar Drugs 2009, 7(2):210-248.
44. Orhana D.D., özcelikb B., özgen S., Erguna F. Antibacterial, antifungal, and antiviral activities of some flavonoids. Microbiol Res 2010, 165:496-504.
45. Patel M., Hegde V., Horan A.C., Gullo V.P., Loebenberg D., Marquez J.A., et al. A novel phenazine antifungal antibiotic, 1, 6-dihydroxy-2-chlorophenazine fermentation, isolation, structure and biological properties. J Antibiot 1984, XXXVII(9):943-948.
46. Pierson L.S, Pierson E.A. Metabolism and function of phenazines in bacteria: impacts on the behavior of bacteria in the environment and biotechnological processes. Appl Microbiol Biotechnol 2010, 86:1659-1670.
47. Pusecker K., Laatsch H., Helmke E., Weyland H. Dydrophencomycin methyl ester: a new phenazine derivative from a marine Streptomycete. J Antibiot 1997, 50(6):479-483.
48. Rainey F.A., Ward-Rainey N., Kroppenstedt R.M., Stackebrandt E. The genus Nocardiopsis represents a phylogenetically coherent taxon and a distinct actinomycete lineage: proposal of Nocardiopsiaceae fam. nov. Int J Syst Bacteriol 1996, 46:1088-1096.
49. Saitou N., Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987, 4(4):406-425.
50. Seo Y.M., Hong S.W. On the isolation of antibiotic producing Streptomyces spp. from soil. Korean J Microbiol 1977, 15:93-99.
51. Shirling E.B., Gottlieb D. Methods for characterization of Streptomyces species. Int J Syst Bacteriol 1966, 16:313-340.
52. Sipali O.R. Economics of antibiotic resistance. Expert Rev Anti-infect Ther 2008, 4:523-539.
53. Spector N., Xia W.L., El-Hariry I., Yarden Y., Bacus S. Small molecule HER-2 tyrosine kinase inhibitors. Breast Cancer Res 2004, 6(5):204-210.
54. Staneck J.L., Roberts G.D. Simplified approach to identification of aerobic actinomycetes by thinlayer chromatography. Appl Microbiol 1974, 28:226-231.
55. Surpin M., Zou Y.F., Xiong C.Y., Raikhel N.V., Pirrung M.C. Iodine scanning of a phenazine inhibitor of vacuolar sorting. Bioorg Med Chem Lett 2010, 20(5):1496-1499.
56. Thangapazham R.L., Sharma A., Maheshwari R.K. Multiple molecular targets in cancer chemoprevention by curcumin. AAPS J 2006, 8:E443-E449.
57. Waksman S.A. Classification identification and descriptions of genera and species. The actinomycetes 1961, 217-233. The Ronald Press Company, New York. S.A. Waksman (Ed.).
58. Weisburg W.G., Barns S.M., Lane D.J. 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol 1991, 173(2):697-703.
59. Williams P.G. Panning for chemical gold: marine bacteria as a source of new therapeutics. Trends Biotechnol 2009, 27:45-52.
60. Wise R. The worldwide threat of antimicrobial resistance. Curr Sci 2008, 95(7):181-187.
61. Wu D.F., Chang H.T., Wang Y., Xin M.X. Isolation, structure determination and antibacterial activities of succinamide conjugate diacid from Acinetobacter sp. BJ-L. Microbiol Res 2011, 166:155-160.
62. Yukimura K., Nakai R., Kohshima S., Uetake J., Kanda H., Naganuma T. Spore-forming halophilic bacteria isolated from Arctic terrains: implications for long-range transportation of microorganisms. Polar Sci 2009, 3:163-169.